---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-26-000032"
form_type: "8-K/A"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2026-07-09T20:43:31+00:00"
generated_at: "2026-07-09T20:45:06.495910+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Prestige files 8-K/A with OTC Wellness Business Q1 2026 financials; net income $12.6M

## Summary
- OTC Wellness Business net sales $51.7M for Q1 2026, up 2.4% YoY from $50.5M.
- Net income $12.6M, down 14.4% from $14.8M in Q1 2025; operating income $12.6M.
- Gross sales $64.1M; sales allowances, returns & discounts $12.4M (19.4% of gross).
- Advertising & promotion expense $12.6M, up 24.6% YoY from $10.2M.
- Filing corrects prior 8-K/A by removing inadvertently included audit report.

## SEC filing metadata
- accession: 0001295947-26-000032
- form_type: 8-K/A
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2026-07-09T20:43:31+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000032/0001295947-26-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000032/pbh-20260612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-26-000032
- JSON: https://secwatch.observer/filing/0001295947-26-000032.json
- Plain text: https://secwatch.observer/filing/0001295947-26-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.